Home > PS Ratio > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of LINCOLN PHARMACEUTICALS is 2.20.

Share Price ₹604.7Apr 30,2024
Market Cap ₹1,209.3 Cr
Sales-TTM₹550.5 CrTTM-Consolidated Results
Price/Sales2.20xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of LINCOLN PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of LINCOLN PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹1,209.3 Cr] as on Apr 30,2024

(/) Sales [ ₹550.5 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 2.20x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for LINCOLN PHARMACEUTICALS , the investors are currently willing to pay '2.20 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of LINCOLN PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of LINCOLN PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of LINCOLN PHARMACEUTICALS


PS Ratio Performance Analysis for LINCOLN PHARMACEUTICALS

- LINCOLN PHARMACEUTICALS 's latest p/e ratio is 2.20x.

- LINCOLN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 1.11x.

- LINCOLN PHARMACEUTICALS 's operated at median p/e ratio of 1.16x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, LINCOLN PHARMACEUTICALS 's p/e ratio peaked in Mar2023 at 1.33x.

- LINCOLN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.69x.


How does LINCOLN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
LINCOLN PHARMACEUTICALS 550.52.201,209.3
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.60360,452.0
CIPLA LTD25,350.24.46113,132.0
DR REDDYS LABORATORIES LTD27,212.53.80103,512.0
ZYDUS LIFESCIENCES LTD19,024.25.0495,954.5
DIVIS LABORATORIES LTD7,492.814.17106,191.0
MANKIND PHARMA LTD9,946.39.5394,779.2
TORRENT PHARMACEUTICALS LTD10,474.08.5389,363.1
LUPIN LTD19,480.13.8574,991.4
AUROBINDO PHARMA LTD27,894.72.4267,526.5
ABBOTT INDIA LTD5,753.49.7656,131.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LINCOLN PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.20x
Max industry PS 14.17x
Median industry PS 5.04x
Average industry PS 6.49x



You may also like the below Video Courses